Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04747834 · ClinicalTrials.gov registry record · NA

Assessment of Low Energy Lens Fragmentation Cataract Extraction in Patients Undergoing Cataract Surgery

A NA study of Cataract, sponsored by Carl Zeiss Meditec.

Completed
Registry status
NA
Development phase
100
Enrollment target
3
Study locations

NCT04747834: Completed NA study of Cataract, sponsored by Carl Zeiss Meditec.

NCT04747834 is a NA study of Cataract that has completed, run by Carl Zeiss Meditec. The registered enrollment target is 100 participants, below the 227-participant average among 83 other Cataract trials with a reported enrollment target (56% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04747834, a NA study of Cataract, has completed, sponsored by Carl Zeiss Meditec.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this research study is to evaluate the clinical outcomes of the use of low-energy segment removal with a micro-interventional irrigation/aspiration port (MICOR-304) to evacuate the lens prior to intraocular lens insertion in subjects undergoing routine cataract surgery.

Primary Outcome

Total lens removal time is defined in two phases: * The beginning time starts when the surgeon enters the eye with the MICOR-304 to start the lens removal process and completing when the surgeon finishes the nucleus lens removal with the MICOR-304 before changing over to irrigation and aspiration. * The second phase of lens removal time is the irrigation and aspiration stage for cortex removal which starts when the irrigation and aspiration tip enters the eye and completion time is when the cor

Conditions Studied

Interventions

  • DEVICE MICOR-304

Study Locations (3)

Alabama

  • Young H. Choi Eye Surgery Center - Vestavia Hills

Florida

  • Argus Research at Cape Coral Eye Center - Cape Coral

Minnesota

  • Chu Vision Institute - Bloomington

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2021-01-06
Est. Completion 2022-01-24
Phase NA
Carl Zeiss Meditec

18 total trials

What the finished NCT04747834 record still lists

NCT04747834 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 227-participant average among 83 other Cataract trials with a reported enrollment target (56% lower).

The record links to 1 condition, with Cataract appearing as the primary indexed condition, and to 1 intervention - of which MICOR-304 is the first listed.

NCT04747834 reports a single indexed study location in Alabama, Florida, Minnesota.

Frequently Asked Questions

What is clinical trial NCT04747834 about?

NCT04747834 is a clinical study titled "Assessment of Low Energy Lens Fragmentation Cataract Extraction in Patients Undergoing Cataract Surgery". The purpose of this research study is to evaluate the clinical outcomes of the use of low-energy segment removal with a micro-interventional irrigation/aspiration port (MICOR-304) to evacuate the lens prior to intraocular lens insertion in subjects undergoing routine cataract surgery.

What is the current status of trial NCT04747834?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2021-01-06. Estimated completion is 2022-01-24.

What conditions does trial NCT04747834 study?

This clinical trial studies the following conditions: Cataract.

What interventions are being tested in trial NCT04747834?

The interventions under investigation include: MICOR-304 (DEVICE).

Who is sponsoring clinical trial NCT04747834?

This trial is sponsored by Carl Zeiss Meditec, which has 18 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04747834 being conducted?

This trial has 3 study locations across Alabama, Florida, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cataract

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04747834's enrollment target sits among peer trials

100 38th of 83 higher than 46 of 83 other Cataract trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cataract trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04747834, the US trial registry maintained by the National Library of Medicine. NCT04747834 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.